Target intelligence / Profile preview

TBC1 domain family member 29, pseudogene (TBC1D29P)

Target
TBC1D29P
Molecular classification
Other, Pseudogene
01

Overview

**TBC1 domain family member 29, pseudogene (TBC1D29P)** is a human genetic locus classified as a pseudogene, meaning it resembles a protein-coding gene but lacks functional coding capacity and is not believed to produce a biologically active protein product[1][2][3][4][5][8][9][10]. TBC1D29P is related by sequence similarity to the TBC1 domain family but does not possess a functional role as an enzyme, transporter, receptor, or other druggable protein and is not considered a therapeutic target.\n\nEssential context and supporting details:\n- **Canonical name, abbreviation, aliases:** The gene is officially designated *TBC1 domain family member 29, pseudogene* (TBC1D29P), with common aliases \"TBC1D29,\" \"DKFZP434O047,\" and \"Putative TBC1 domain family member 29\"[1][2][3][4][5].\n- **Molecular classification:** Listed as a pseudogene, it lacks the features and activity typical of protein-coding genes; does not belong to any classical receptor, enzyme, transporter, or transcription factor families[1][2][3][4][10].\n- **Function:** No confirmed biological function, enzyme, or receptor activity has been ascribed to TBC1D29P[2][3][10].\n- **Disease role:** No association with human disease, therapeutic targeting, or biomarker use is documented[2][3][8][10].\n- **Drug interactions/mechanisms:** No known drugs interact with TBC1D29P, nor have any mechanisms of action been described for therapeutics targeting this pseudogene[2][3][10].\n- **Correction of premise:** TBC1D29P is not a classical pharmacological or therapeutic target; it is a non-coding genomic element, so entries like function, interacting drugs, mechanism of action, biomarker status, and safety concerns are not applicable.\n\nIf you are seeking a functional or druggable target within the TBC1 domain family, another family member such as **TBC1D1** or **TBC1D4** would be more relevant[7].

Other names
TBC1D29DKFZP434O047Putative TBC1 domain family member 29

Beyond the preview

Go deeper on TBC1 domain family member 29, pseudogene (TBC1D29P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC1 domain family member 29, pseudogene (TBC1D29P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call